Plain-English translation of NCT06319482 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether a breathing device enhanced with artificial intelligence (AI) can help people with sleep apnea stick with their treatment better than the standard breathing device. Sleep apnea causes people to stop breathing repeatedly during sleep, and special breathing machines can help. Researchers want to see if this new AI-powered version encourages patients to use their device more consistently.
Many people with sleep apnea struggle to use their breathing machines regularly, even though consistent use is important for their health. This trial exists to see whether the new treatment with AI assistance can make it easier for patients to stay committed to their therapy and get better results.
You likely qualify if…
You likely don't qualify if…
You will receive a breathing device and be randomly assigned to either the new AI-powered version or the standard version. A sleep technician will check in with you regularly to see how you're doing. For the first 3 months, you'll use the device at home and fill out questionnaires about your experience. If the treatment is working well for you, you'll have the option to continue for 9 more months. Your device will automatically track how often you use it and how well it's working.
AI-generated summary from trial data · Jun 6, 2026 · Not medical advice
Canada